Sign In
Buy HRMY
$32.10
+1.19 (+3.85%)
At Close: Jun 03, 2026
5 Stocks for Higher Returns as Analysts Initiate Coverage
10:50am, Tuesday, 28'th Sep 2021
Increased analyst coverage over the past few weeks might lead to solid price appreciation for stocks like Alpha and Omega (AOSL), Preferred Apartment (APTS), Hut 8 Mining (HUT), GCM (GCMG) & Harmony B
Harmony Biosciences Announces Winners of Patients at the Heart and Progress at the Heart on Third Annual World Narcolepsy Day
08:05am, Wednesday, 22'nd Sep 2021
PLYMOUTH MEETING, Pa., Sept. 22, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative t
Harmony Biosciences To Participate In Three Investor Conferences In September
08:05am, Thursday, 02'nd Sep 2021
PLYMOUTH MEETING, Pa., Sept. 2, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative the
Harmony Biosciences Stock Is Trading Higher On $330M Financing Deal With Blackstone, Q2 Earning Beat Estimates
03:52pm, Tuesday, 10'th Aug 2021
Harmony Biosciences Holdings Inc (NASDAQ: HRMY) has entered into a $330 million financing collaboration with The Blackstone Group Inc (NYSE: BX). The financing deal includes up to $300 million in
Harmony Biosciences Holdings, Inc. (HRMY) CEO John Jacobs on Q2 2021 Results - Earnings Call Transcript
02:47pm, Tuesday, 10'th Aug 2021
Harmony Biosciences Holdings, Inc. (HRMY) CEO John Jacobs on Q2 2021 Results - Earnings Call Transcript
HRMY Stock Price Increases Over 20% Intraday: Why It Happened
01:49pm, Tuesday, 10'th Aug 2021
The stock price of Harmony Biosciences Holdings Inc (NASDAQ: HRMY) increased by over 20% during intraday trading. This is why it happened.
Harmony Biosciences Reports Second Quarter 2021 Financial Results and Business Updates
08:00am, Tuesday, 10'th Aug 2021
WAKIX® (pitolisant) Net Revenue of $73.8 Million for Second Quarter 2021 vs. $38 Million for the Same Period in 2020
PLYMOUTH MEETING, Pa., Aug. 9, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative
PLYMOUTH MEEETING, Pa., July 29, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative th
Harmony Biosciences Announces Date Of Second Quarter 2021 Financial Results
07:30am, Tuesday, 27'th Jul 2021
PLYMOUTH MEETING, Pa., July 27, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializi
Harmony Biosciences Is Likely To Trade Higher As Wakix Sales Build
01:06pm, Tuesday, 13'th Jul 2021
Harmony Biosciences Is Likely To Trade Higher As Wakix Sales Build
Harmony Biosciences Initiates A Phase 2 Clinical Trial In Myotonic Dystrophy
08:05am, Tuesday, 29'th Jun 2021
PLYMOUTH MEETING, Pa., June 29, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative th
Harmony Biosciences Presents New Analysis Of Clinical Impact For WAKIX® (pitolisant) At The SLEEP 2021 Annual Meeting
08:05am, Thursday, 10'th Jun 2021
PLYMOUTH MEETING, Pa., June 10, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative th
Harmony Biosciences Announces Applications for 2021 Patients At The Heart Grant Program Open June 9
08:05am, Wednesday, 09'th Jun 2021
PLYMOUTH MEETING, Pa., June 9, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative the
Harmony Biosciences To Present New Data Analyses For WAKIX® (pitolisant) At The SLEEP 2021 Annual Meeting
08:05am, Monday, 07'th Jun 2021
PLYMOUTH MEETING, Pa., June 7, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative th
